abrea 75 mg zarnās šķīstošās tabletes
krka, d.d., novo mesto, slovenia - skābes acetylsalicylicum - zarnās šķīstošā tablete - 75 mg
abrea 160 mg zarnās šķīstošās tabletes
krka, d.d., novo mesto, slovenia - skābes acetylsalicylicum - zarnās šķīstošā tablete - 160 mg
abrea 100 mg zarnās šķīstošās tabletes
krka, d.d., novo mesto, slovenia - skābes acetylsalicylicum - zarnās šķīstošā tablete - 100 mg
rhinallergy tabletes
boiron, france - ambrosia artemisiaefolia, euphrasia officinalis, histaminum muriaticum, šenokaulons (schoenocaulon officinale, solidago virgaurea, Ķiploku un sīpolu - tablete
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiski līdzekļi - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
sunitinib teva 12,5 mg cietās kapsulas
teva b.v., netherlands - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib teva 50 mg cietās kapsulas
teva b.v., netherlands - sunitinibs - kapsula, cietā - 50 mg
sunitinib sandoz 37,5 mg cietās kapsulas
sandoz d.d., slovenia - sunitinibs - kapsula, cietā - 37,5 mg
sunitinib sandoz 12,5 mg cietās kapsulas
sandoz d.d., slovenia - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib mylan 12,5 mg cietās kapsulas
mylan ireland limited, ireland - sunitinibs - kapsula, cietā - 12,5 mg